NCT04458792 Establishment of a Prospective Clinical-biological Database
| NCT ID | NCT04458792 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle |
| Condition | Sarcoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 450 participants |
| Start Date | 2016-11 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 450 participants in total. It began in 2016-11 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical data to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to Sarcoma
Eligibility Criteria
Inclusion Criteria: * men or women \> 18 years * Patient treated by surgery for : a primitive sarcoma and/or local relapse sarcoma and/or metastatic localisation of sarcoma * patient accepted blood sample * patient treated by radiotherapy before or after the surgery * Patient signed informed consent Exclusion Criteria: * Patient not affiliated to french Social Protection system * Patient under guardianship * Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons * Pregnancy and/or feeding * Patient take care in an Emergency Situation
Contact & Investigator
FIRMIN Nelly, MD
STUDY CHAIR
Institut régional du Cancer Montpellier
Frequently Asked Questions
Who can join the NCT04458792 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04458792 currently recruiting?
Yes, NCT04458792 is actively recruiting participants. Contact the research team at DRCI-icm105@icm.unicancer.fr for enrollment information.
Where is the NCT04458792 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT04458792 clinical trial?
NCT04458792 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle. The principal investigator is FIRMIN Nelly, MD at Institut régional du Cancer Montpellier. The trial plans to enroll 450 participants.